Device Cardiovascular Care

Heartstring III Proximal Seal

Payments companies reported to CMS as associated with Heartstring III Proximal Seal. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$27Kassociated payments (2023-2025)
273clinicians with associated payments
2companies reporting

By year

2023 $6,419
2024 $9,682
2025 $11K

Payments reported as associated with Heartstring III Proximal Seal, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Thoracic Surgery (Cardiothoracic Vascular Surgery) $11K
Physician Assistant $4,761
Surgical $4,544
Anesthesiology $1,339
Nurse Practitioner $874
Interventional Cardiology $431

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Heartstring III Proximal Seal

These are the largest totals companies reported as associated with Heartstring III Proximal Seal. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Seyed Mohammad Khalafi Fort Worth, TX Thoracic Surgery (Cardiothoracic Vascular Surgery) $2,574.81
Samuel Baumguardner Midland, TX Physician Assistant $603.87
Kirit Patel Midland, TX Thoracic Surgery (Cardiothoracic Vascular Surgery) $603.87
Tung Huu Cai Denton, TX Thoracic Surgery (Cardiothoracic Vascular Surgery) $588.15
Shakeel Sharif Fort Worth, TX Surgical $576.82
Darien Bradford Burleson, TX Thoracic Surgery (Cardiothoracic Vascular Surgery) $542.03
Michael Hester Midland, TX Nurse Practitioner $470.53
Alison Ranade Sacramento, CA Surgical $384.88
James Anderson Fort Worth, TX Thoracic Surgery (Cardiothoracic Vascular Surgery) $361.14
Leah Colburn Houston, TX Surgical $357.76

Prescribed Heartstring III Proximal Seal?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.